It is morally wrong to make a mother choose between treatment for herself and treatment for her newborn. It is morally wrong that people should be dying of AIDS when treatment is available.
It is morally wrong that babies are still being born with HIV when we know how to prevent it. It is morally wrong that children are still growing up as AIDS orphans.
To be a partner for women and girls against violence and injustice, you do not have to be experts on human rights or gender. You do have to be committed to always asking in your daily work: 'How can I better engage women and girls to understand what they need'
A society that cuts itself off from its youth severs its lifeline; it is condemned to bleed to death.
When the history of our times is written, will we be remembered as the generation that turned our backs in a moment of global crisis or will it be recorded that we did the right thing?
No disease group is as vast and complex in scope as the noncommunicable diseases (NCDs). Incorporating social determinants such as income and education, the NCDs call for an equally massive and comprehensive response
There are 1.2 billion adolescents across the world, 9 out of 10 of these young people live in developing countries. Millions are denied their basic rights to quality education, health care, protection and exposed to abuse and exploitation.
Of all the forms of inequality, injustice in health care is the most shocking and inhumane.
“The early years in a child’s life—when the human brain is forming—represent a critically important window of opportunity to develop a child’s full potential and shape key academic, social, and cognitive skills that determine a child’s success in school and in life.”—President Barack Obama
“If art is to nourish the roots of our culture, society must set the artist free to follow his vision wherever it takes him.”—President JF Kennedy
"The true character of a society is revealed in how it treats its children. History will judge us by the difference we make in the everyday lives of children."—President Nelson Mandela


Online Submissions

Already have a Username/Password for International Journal of Maternal and Child Health (MCH) and AIDS (IJMA)?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

To submit an article, please ensure that you are registered as an author.


Author Guidelines


Manuscript submissions are free. 

Prospective authors are highly encouraged to review every section of this author instruction in order to ensure that they are submitting manuscripts that comply with the laid-out instructions. To say it simply, if you want your manuscript to be expedited, do your part and simply follow the instructions laid out in this document.

Article Types

IJMA considers the following types of articles for publication:

Original Research Article

This will be reports of data from original research conducted by researchers.

Methodology Articles

These comprise of presentations of novel statistical, demographic, and public health applications and techniques, experimental methods, tests, or procedures. These articles must demonstrate how the new method improves upon what is currently in existence in the field of professional practice. Methodology articles undergo full peer-review.

Brief Research, Short Report, or Rapid Communication

These are brief reports of data from original research. Authors of rapid communication may be asked to sign an agreement to publish the full paper in IJMA prior to publication of rapid communication. Short reports and communication undergo full peer-review.

Case Reports

These are reports of medical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Authors of all case report articles should indicate that informed consent to publish the information was granted from the patients or their guardians and must submit such authorization if requested. Case reports undergo full peer-review.

Field Studies or Case Studies

These are descriptions of a major program intervention or policy option that is adjudged to be relevant to the fields of MCH and HIV/AIDS. Case study articles should include a rigorous assessment of the processes and the impact of the study, as well as recommendations for the future. These undergo full peer-review.

Editorial and Commentary

These are short, focused and opinion articles addressing emerging issues in maternal, neonatal, and child health, HIV/AIDS, and social determinants of health. These usually set the stage for galvanizing further action in the issues addressed. These are reviewed by at least one reviewer.

Review Articles

These are comprehensive, authoritative, descriptions of any subject that addresses existing or emerging areas in all aspects of maternal, neonatal, and child health and HIV/AIDS. IJMA complies with the international standards for reporting of review articles.  IJMA prefers that review articles conform to the PRISMA or other international standards for reporting systematic reviews. Please review the PRISMA statement here for more information about the PRISMA standard.

Authors interested in submitting review articles should contact the editorial office prior to manuscript preparation and submission by sending an e-mail to

Book Reviews

These are short summaries of the strengths and weaknesses of a new book in the field evaluating the book’s usefulness in the fields of MCH and HIV/AIDS. Authors who plan to review relevant books must contact the Editor-in-Chief for more information.

Letters to the Editor

These are published responses to articles previously published in the journal and responses by the authors of the work so referred if the Letter to Editor substantially adds to the findings of the prior article in question. Letters to the Editor are limited to reactions to two prior issues of the journal. All Letters to the Editor are reviewed but are not peer-reviewed.

Conference Reports

These are short descriptions of a conference that the author has attended, which focuses on the key developments presented and discussed at the meeting. Meeting reports must address MCH and HIV/AIDS.


IJMA welcomes inquiries about publishing supplements. The proposal to publish the contents, (articles or meeting abstracts) should be addressed to the Managing Editor. All Supplements are subject to the editorial policy and guidelines.


Manuscript Preparation

IJMA accepts manuscripts written in American ENGLISH only. Manuscripts are to be typed double-spaced using American English spelling ONLY. Manuscripts that do not adhere to the word limits may be returned to the authors. 

All manuscripts should be submitted by the corresponding author. Submissions by anyone other than the corresponding author will not be accepted. Manuscripts should be submitted as Microsoft Word document ONLY (no PDFs). All tables and figures should be incorported into one document. Avoid the use of special formatting. 

After submitting your manuscript, corresponding authors are advised to add the journal’s email address to their email contacts. This will prevent emails from the journal from being delivered to your email spam/junk mailbox.

Word Limits

The table below provides a guide on word limitations for different types of manuscripts


Type of Manuscript

Number of Words

Letter to the Editor


Original Research Articles


Editorials or Commentary


Short or Rapid Communication


Field Studies or Case Report


Policy and Practice


Conference Report


Methodology Articles


Review Articles

Negotiate with Editors

Book Reviews



Manuscript Format

Title and Authorship Page

The title page should be single-spaced. It should contain following information: 

  • Manuscript title
  • Full name of authors including highest degrees and professional degrees only.
  • Full institutional address of all authors (including ZIP code, if applicable)
  • Telephone number with area codes
  • E-mail addresses of all authors
  • Identification of one corresponding author with contact information (email address and telephone number(s)).


The manuscript should contain an abstract. The abstract should be self-contained, free of citations, and not exceed 250 words. Abstracts should be structured with the following five sections: 

(1) Background /Objectives, (2) Methods, (3) Results, (4) Discussion, (5) Conclusions and Global Health Implications.

Background and Objectives

This section provides an introduction and overview including what is known in the field. It should be succinct, with no subheadings. This is where you state what is known in the field and what is lacking using, if preferred the "deficiency model" in identifying gaps in current/prior research and practice. This is where you provide the statement of the problem followed by the objectives of your present study. This is where you make the argument why we should publish this paper.


This part should contain sufficient detail so that all procedures can be replicable by other researchers. Authors may divide this into subsections if several methods are described. The methodology should be precise but with sufficient detail to guide scientific replicability. It should not be laborious. If the method is well-known and described elsewhere, please refer your readers to those sources. Include information about the approval of the study stating which Institutional Review Board or Ethics Board approved the study or granted exception.


This section may each be divided by subheadings or may be combined. It provides the findings of the study without discussions. Begin with the key findings and work down to the last finding. Please limit all numbers to two decimal places. 


The discussion section should be as concise as possible and should include a brief statement of the principal findings, a discussion of the validity of the observations, a discussion of the findings in light of other published work dealing with the same or closely related subjects, and a statement of the possible significance of the work. It should also include strengths and weaknesses of the paper and unanswered questions and future research. Extensive discussion of the literature is discouraged in this section.

Conclusions and Global Health Implications

You may decide to separate these into two sections or one section.  This section should clearly explain the main conclusions of the work; it should highlight the work’s importance and relevance to both practice and policy. This section should address the “so what?” question addressed by the paper. What is the contribution that this paper will make to the field? This is also the place where limitations of the study, including but not limited to the design, methods, or dataset, should be discussed.

Key Words

Authors should provide a list of 6-10 key words directly below the abstract.  Key words should express the precise content of the manuscript, as they are used for indexing and search purposes. To the extent possible, select key words from the NIH Medical Subject Headings (MeSH).


Acknowledgement should be included at the end of the paper before the references. It should contain information about research support grants, fellowships, and presentations. This is a place to list contributors who do not meet the criteria for authorship such as people who provided technical help or writing assistance.  Also include here details of any organization that has made a contribution to your research such as funding organization.  Authors are responsible for obtaining permissions from all the people acknowledged before putting their names in the manuscript.

Conflict of Interest

The author(s) should state if they have any conflict of interests regarding the paper.  If there is, please state clearly what the conflict(s) is or are.


The authors should state the funding source, if applicable. 

Key Messages

Include 3-5 bullet points of the major findings of your manuscript. These should be stated like elevator pitches which can be rehearsed within a short period of time.  The key messages should come immediatley before references.

Journal Style/Formatting

IJMA follows the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals as outlined by International committee of Medical Journal Editors (ICMJE).

All aspects of the manuscript, including the formatting of tables, illustrations, and references and grammar, punctuation, usage, and scientific writing style, should be prepared according to the most current AMA Manual of Style. The AMA (sometimes referred to as the JAMA) style is available in most reference management softwares such as EndNote, Reference Manager, etc. 


Authors are responsible for ensuring that the information in each reference is complete and accurate. With the exception of review articles, manuscripts should have no more than 30 references.  

References should follow the AMA Manual of Style, current edition. However, for IJMA, list all authors. Abbreivated journal names should follow the Index Medicus style.   

References must be numbered consecutively and citations of references in text should be identified using numbers in superscript (e.g., “as discussed by Johnson;9” “as discussed elsewhere. 9, 10

All references should be cited within the text; otherwise, these references will be automatically removed from the manuscript.  Authors are strongly advised to review any of the papers published in the journal for sample of article preparation. The editors reserve the right to delete references during the review process.  

Note that punctuation marks come before the citation square brackets. Please minimize the use of internet references as these links in many occasions break and are no longer functional.

Sample AMA Style Citations and References

  1. Singh GK, Siapush M, Kogan MD. Rising social inequalities in US childhood obesity, 2003-2007. Annals of Epidemiology. 2010; 20(1):40-52.
  2. Azuine MA, Tokuda H, Takayasu J, Enjyo F, Mukainaka T, Konoshima T, Nishino H, Kapadia GJ. Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis models. Pharmacological Research. 2004; 49(2):161-169.
  3. Azuine R, Russell J, Clark S, O’Brien C, Rowell H, Lansdowne N. The outlook for a new generation. Nursing Times. 2004 2; 100(4):28-29.

Tables, Figures, and Illustrations

Tables and figures should be numbered and referred to by number in the text. Each table or figure should be typed on a separate page and should have a descriptive title.  Attach the tables and the figures at the end of the manuscript after the references.  

Illustrations (photographs, drawings, diagrams, and charts) are to be numbered in one consecutive series of Arabic numerals, and referred to by number in the text. Photographs should be high-contrast and drawings should be dark, sharp, and clear.  

Artwork for each figure should be provided on a separate page. Each figure should have an accompanying caption. The list of captions for illustrations should be typed on a separate page. There should be no more than three tables or figures for a full research paper.  Extra tables and figures may be published at extra cost to the authors.

Units of Measurement

Authors of manuscripts are advised to present units of measurement using System International (SI) units.


Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. That this manuscript is being submitted only to the International Journal of MCH and AIDS (IJMA), that this manuscript shall not be submitted elsewhere while under consideration, that it has not been published elsewhere, and, should it be published in IJMA, that it shall not be published elsewhere—either in similar form or verbatim—without permission of the editors. (Note: These restrictions do not apply to abstracts or to press reports of presentations at scientific meetings and conferences).

  2. That all authors listed on this manuscript have made substantive intellectual contributions to the manuscript with regards to conception and design, acquisition of data, or analyses and interpretation of data, drafting the article or revising it critically for important intellectual content; and that they all have given a final approval of the version to be submitted for publication.
  3. That all authors have discussed and decided the authorship issues, including the order in which the authors would be listed in the published paper, before submission.

  4. That all authors understand that IJMA is an open-access journal and that, if accepted for publication, we fully understand that we shall be required to pay an article processing charge prior to the final publication of our paper.

  5. That all authors have complied with the necessary local and international regulations regarding conduct of research, including declaration of conflict of interest, disclosure of financial interest, and institutional review board approval, where necessary, in the preparation of this manuscript. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  6. That the authors have obtained the necessary approvals in adherence with the local and international policies and used the standardized form of the International Committee of Medical Journal Editors and other ethical guidelines outlined by the journal and guiding the universal conduct of research; and shall make all efforts to submit any approvals, if needed.


Copyright Notice

Articles published in IJMA are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Publication Policies

IJMA subscribes, and will continue to subscribe, to the best ethical principles in the publication of scientific work. The policies published here are meant to provide general guidelines and are in tandem with the best practices adopted (and disseminated) by many prominent publishers, scientific journals, and scientific publication forums across the world. The policies outlined here are living policies and will thus be updated as necessary. Submission is a representation that the manuscript has not been published previously and is not currently under consideration for publication elsewhere (except in the form of an abstract or as part of a published lecture, review, final project, thesis or dissertation). The corresponding author is responsible for ensuring that the article’s publication has been approved by all the other coauthors. It is also the authors’ responsibility to ensure that the articles emanating from a particular institution are submitted with the approval of the necessary institution. Only an acknowledgment from the IJMA editorial office officially establishes the date of receipt. Further correspondence and proofs will be sent to the corresponding author before publication unless otherwise indicated. It is a condition of submission of a paper that the authors permit editing of the paper for readability. All enquiries concerning manuscripts under consideration should be addressed to the Editor-in-Chief via email

Peer Review

Every submission for a featured manuscript is evaluated by at least two reviewers. Reviewers help the Editor-in-Chief determine the paper’s relevance and significance, the degree to which it advances knowledge, the quality of scholarly presentation, the integrity of research methods, and content relevant to MCH and HIV/AIDS.


All articles published by IJMA are made freely accessible online immediately upon publication, without subscription charges or registration barriers. By doing this, authors’ works become accessible to the widest scientific and professional audience around the world especially in resource-limited parts of the world. In addition, authors of articles published in IJMA are the copyright holders of their articles and have granted to IJMA, the right to use, reproduce, or disseminate the article according to the journal’s copyright and license agreement.

Authors must obtain the written permission from the copyright owner (usually the author and publisher) for the use of tables, illustrations, or extensively quoted material which has previously appeared in another publication. The authors are responsible for any costs incurred relating to obtaining permissions for any such material.


Article Processing Charges

Author Fees Based on Location

  • Developed (Tier 1) Countries: $500
  • Developing & Emerging (Tier 2) Countries = $300


Ethical Guidelines

To maintain high scientific quality, our editorial processes and practices follow guidelines/policies issued and updated by the following organizations: Committee on Publication Ethics (COPE); International Committee of Medical Journal Editors (ICMJE), councile of Scienitif Editors (CSE); and world Association of Medical Editors (WAME). To read more about this information, click here.


Open Access: In addition to strict compliance with the above guidelines, our open-access publishing practices follow best practices, guidelines, and policies outlined in The Principles of Transparency and Best Practice in Scholarly Publishing issued by COPE, Open Access Scholarly Publishers Association (OASPA), and Directory of Open Access Journals (DOAJ).

IJMA is indexed in DOAJ, and will be subjected to the required evaluation and re-evalaution for open-access publishing best practices as established and updated by DOAJ.

This journal will subscribe to and comply with best practices for open-access publishers as established and advocated by OASPA. 

Authors should describe in detail all new experimental and non-experimental research methods and ethically relevant aspects of their work bearing in mind the following:

Human Experiments

All work must be conducted in accordance with the Declaration of Helsinki (1964). Papers describing experimental work on human subjects who carry a risk of harm must include the following statement:

“I/we declare that the experiment described in this manuscript was conducted with the understanding and the consent of the human subject.”

In addition, please add a statement that the responsible Ethical Committee or Institutional review Board has reviewed and approved the study/experiments.

Animal Experiments

Papers describing experiments on living animals should provide information on the following:

  • A full description of any anesthetic and surgical procedure used.
  • Evidence that all possible steps were taken to avoid animal suffering at each stage of the experiment. Papers describing experiments on isolated tissues must indicate precisely how the donor tissues were obtained.

In all cases, IJMA reserves the right to ask authors for more information about their treatment of human and animal subjects in their work prior to publication.

IJMA is one of the few scientific journals in the world that endorses the principles and guidelines for reporting preclinical research led by the U.S. National Institutes of Health (NIH). Click here to read more about this guideline and its implication for ypur manuscript submission.

IRB Approval

IJMA requires that all studies that involve human subjects or participants be approved or deemed exempt by an official institutional review board or ethics review board as applicable in the authors’ country. Information about ethical approvable must be clearly stated in the Methodology section of the manuscript before submission.

Informed Consent

IJMA requires that authors obtain requisite informed consent and/or assent or other applicable consent from all human subjects or participants in their study. Authors are required to state whether and how informed consent/assent was obtained in their study in their manuscript.

In reporting their studies, authors should avoid the use of names, initials, and hospital numbers of patients/volunteers or study participants or subjects. In very rare circumstances where the authors are submitting photographs of study participants, these individuals should not be recognizable from photographs unless their written permission has first been obtained.

Please contact the editorial office before submitting any videos, photographs, or other images of study participants.

Editorial Principles and Compliance with ICMJE Recommendations

IJMA adheres to the finest editorial principles to ensure that the work it publishes are accurate, timely, fair and conform to the best ethical principles of publication of scientific papers as outlined here and may be updated from time to time. We believe that principles like those outlined here provide clear and clarity and rigorous guidelines for best working practices in scientific publishing and for ensuring the integrity of the papers that we publish. We believe that these principles and policies will benefit our authors, editors and readers as we strive for a trustworthy, transparent and efficient publishing process. IJMA Editor-in-Chief is a member of the World Association of Medical Editors, a global nonprofit voluntary association of editors of peer-reviewed medical journals. This ensures that our editorial policies comply with the best practices in medical and scientific publishing across the world,


Editors and reviewers are expected to treat articles they handle confidentially. Editors and reviewers must not disclose information about manuscripts (including their receipt, content, status in the publishing process, reviewer feedback and final decision) to anyone, other than the authors.

Objectivity and Fair Play

An Editor will evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors. Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

Integrity of the Scientific Record

IJMA is committed to maintaining the integrity of the published record and to publishing the most objective and unbiased scientific information possible. As such, we subscribe to the principles adopted by the Committee on Publication Ethics (COPE), and follow the COPE’s Code of Conduct.

Research misconduct includes fabrication, falsification, or plagiarism in proposing, performing, or reviewing research, or in reporting research results, according to experts. If a suspicion or allegation of scientific misconduct or fraudulent research is brought to the journal’s attention concerning a manuscript submitted for review, IJMA reserves the right to raise these concerns with other relevant institutions or other appropriate authorities for investigation. In the handling and resolution of such cases, we follow COPE’s guidance and recommendations

IJMA will take all necessary steps to maintain the accuracy and quality of the papers it publishes. To this end, IJMA will publish correspondence about papers and publish Errata and Corrigenda when appropriate. In cases of serious error or scientific misconduct, it may be necessary to ask authors to retract their papers or to impose retraction upon them. Should an author discern a significant error or inaccuracy in the published article, they are responsible for notifying IJMA Editor-in-Chief or publisher, and should work together with them to retract or correct the paper. If the Editor-in-Chief or the publisher learns that a published article contains a significant error, the author will be asked to correct or possibly retract the paper, or assist verification by the Editor-in-Chief of the correctness of the original paper.

Errata and Corrigenda

Should an error appear in a published article that affects scientific meaning or author credibility but does not affect the overall results and conclusions of the paper, our policy is to publish a correction in print and online in the next available issue of the journal. If an error is introduced by the publisher during the editing and/or proofing stages, the journal takes responsibility and a correction is published as an Erratum, with appropriate apologies to authors and readers. If an error is introduced by the authors, the correction is published as a Corrigendum and the author is required to pay all costs associated with the correction.


Should a paper contain one or more significant errors or inaccuracies that change some or all of the results or conclusions described therein, the entire paper may be retracted. The word ‘retraction’ will be used in the title of the retraction to ensure that it is picked up by indexing and archiving systems. The journal will request an explanation from the author(s) as to how the errors or inaccuracies occurred, and if they are not satisfied with the response they will ask the employers of the authors or some other appropriate body to investigate, and particularly to consider the possibility of fraudulent behavior. The journal will make all reasonable attempts to ensure that such an investigation is carried out with due diligence. To the extent possible, we will assist the parties and their institutions in the resolutions of these cases.

Should an author discern a significant error or inaccuracy in the published article, they are responsible for notifying IJMA, and should work together with the journal to retract or correct the paper. If the journal learns that a published article contains a significant error, the author will be asked to correct or possibly retract the paper, or assist verification by the Editor-in-Chief of the correctness of the original paper.

Redundant or Concurrent Publication

Research manuscripts that describe work already published elsewhere will not be considered. The submission of the same manuscript to more than one journal concurrently is also considered to be unethical practice. This does not prevent journals from considering articles that have been rejected by other journals or that were not previously published in full (e.g. abstracts or posters presented at scientific meetings).

When submitting, authors should declare any previous submissions or reports that might be regarded as redundant or duplicate publication. Copies of any such related articles should be included with the submitted manuscript to assist editorial decision making. If redundant publication is attempted or occurs, editorial action will be taken, including probable rejection or publication of a notice of redundant or duplicate publication.


Plagiarism is the “use of others’ published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source” see – the World Association of Medical Editors web site). It is considered a dishonest and unacceptable practice. By submitting an article, authors are thereby asserting that their work is entirely original and that others’ work or text has been appropriately cited or attributed.

IJMA is committed to the publication of high-quality, original, research in the field of MCH and HIV/AIDS, and public health in general. The journal editors and publisher will take every step to ensure that, to the best of their knowledge, papers published in the journal are original and conform to the best ethical principles. This includes the use of proprietary and open-source anti-plagiarism screening services and software to verify the originality of content submitted before publication. Manuscripts found to have been plagiarized will be automatically rejected and the editors reserve the right to notify appropriate agencies or the institutions of the corresponding authors.

Author Contributions

IJMA complies with the International Committee of Medical Journal Editors guidelines in the definition of authorship. An author is someone who has made significant and substantial contributions to a study. This should include conception, design, execution and interpretation of the findings being published, and drafting and revising the article. Papers must be submitted with the agreement of all authors, and all authors should give final approval of the version to be published. Those who have made other contributions to the work, such as by providing reagents or assisting with the writing, should be listed in the Acknowledgements, and their role or involvement outlined. Mentees of authors who participate in our IPMP will be included as authors due to the substantial nature of the methodological and editorial support provided to the mentee in the development of the manuscript and its preparation for peer-review and eventual acceptance.


Open Access: In addition to strict compliance with the above guidelines, our open-access publishing practices follow best practices, guidelines, and policies outlined in The Principles of Transparency and Best Practice in Scholarly Publishing issued by COPE, Open Access Scholarly Publishers Association (OASPA), and Directory of Open Access Journals (DOAJ).

This journal is indexed in DOAJ, and will be subjected to the required screening and rescreening for open-access publishing best practices as established and updated by DOAJ.


Privacy Statement

IJMA is a peer-reviewed, open-access print and on-ine journal published by the Global Health and Education Projects, Inc. (GHEP).  GHEP is a US 501(c)(3) non-profit organization that strives to address the social determinants of health and elimination of health disparities across the world.

GHEP publications platform and websites include the various components referred to above including all journal content products, services, features, functionalities, content related sites, and other information accessible through the IJMA Network portal [whether provided by GHEP or any third party], related sites include IJMA on Facebook, IJMA on Twitter, IJMA on Linkedin, e-mail addresses and other personal information. The GHEP websites and IJMA portal are committed to preserving site visitors’ privacy of personal information. The IJMA portal does not collect personal information from a site visitor unless that visitor explicitly and intentionally provides it.

Collection, retention, and use of personal information about site visitors will occur if you choose to interact with the GHEP. for example, you can choose to subscribe to IJMA and/or the IJMA resources,  receive e-mail notifications regarding tables of contents, topic collections, and article alerts whether or not you are a subscriber, or learn about new offerings from the GHEP. Depending on the type of product or service that you request, you may be asked to provide different personal information. The IJMA portal may require your name, address, telephone number, e-mail address, credit card number, Internet protocol (IP) address, and/or other identifying information. For a specific listing of the type of personal information collected, please refer to the appropriate online form.

The GHEP portal may use your personal information collected via the sites (in addition to the e-mail address information use outlined above) for the following purposes:

  • Provide access to journal content.
  • Process, fulfill, and follow-up on orders.
  • Answer your e-mails.
  • Send information you request.
  • Send and process surveys.
  • Ensure the GHEP Publications are relevant to your needs.
  • Recommend content that suits you.
  • Notify you about new products/services, special offers, upgrades and other related information from IJMA and other GHEP Publications.

All e-mail alerts contain an “unsubscribe” option in case you want to discontinue the alert(s) at any time.

The GHEP portal also occasionally hires other companies to provide limited services on our behalf, including, but not limited to, packaging, mailing, and delivering purchases, answering customer questions about products or services, sending postal mail, and processing event registration. We will provide those companies only the information they need to deliver the service, and they are prohibited from using that information for any other purpose.

The GHEP portal may disclose your personal information if required to do so by law or in the good-faith belief that such action is necessary to: (a) conform to legal requirements or comply with legal process served on GHEP; (b) protect and defend the rights or property of GHEP; or (c) protect the personal safety of GHEP personnel or members of the public in urgent circumstances.

In addition to the uses identified above, if the site visitor changes his or her personal information on the GHEP portal, that information may be incorporated into the GHEP database commonly known as the GHEP database.

Advertising. The GHEP websites and portal use third parties to serve advertisements and analyze related data. Non-identifiable website visitor data may be collected and used in aggregate to determine the type of advertisement to be seen by site visitors while on the IJMA portal. Advertisements use persistent cookies (defined below) to identify the number of unique computers from which viewers have viewed an advertisement and to manage the number of times a viewer will see an advertisement and similar advertising efficiencies. No personally identifiable information is collected from the persistent cookie.

Website Analytics.Non-identifiable website visitor data may be collected and used in aggregate to help shape and direct the creation and maintenance of content.

Cookies.A cookie is a small file stored on the site user’s computer or Web server and is used to aid Web page navigation. Session cookies are temporary files created when a user signs in on the website or uses the personalized features such as purchasing temporary access to an article or site-wide access. Session cookies are removed when a user logs off or when the browser is closed. Persistent cookies are permanent files and must be deleted manually. Persistent cookies are used on the GHEP portal (1) when a user asks to save user name and password to prevent the need to enter this information again; (2) by advertisements to identify the number of unique computers from which viewers have viewed an advertisement and to manage the number of times a viewer will see an advertisement and similar advertising efficiencies; (3) by quiz and poll features to determine when an individual has already responded or voted; (4) to retain article preference settings; and (5) to maintain shopping cart items. No personally identifiable information is collected from the latter persistent cookie, and only the user name and password is collected for the former persistent cookie and the session cookie; (3) Electronic Store Shopping Cart; and (4) Web Analytics measuring time or site and number of visits.

E-mail messages. E-mail messages sent to or from a website may not be secure. Confidential information should not be sent by e-mail. Site visitors sending e-mail accept the risk that a third party may intercept e-mail messages.

You may opt out of any future contacts from us at any time. Contact us via the phone number or contact form on our website at any time to:

  • See what data we have about you, if any;
  • Change/correct any data we have about you;
  • Ask us to delete any data we have about you; and/or
  • Opt out of some or all future communications from us.

If you have any additional questions or concerns about this privacy policy, please contact us via the phone number listed on this website.

User-Generated Content. Any data or personal information that You submit to us as user generated content becomes public and may be used by GHEP in connection with GHEP network/friends our digital applications, and other IJMA publications in any and all media.

Policy Revisions.As the GHEP portal evolves over time, this Privacy Policy is expected to change as well. The GHEP reserves the right to amend this Privacy Policy at any time, for any reason. We will post notice that this Policy has been amended by revising the “last updated” date at the top of the Privacy Policy.

Online Policy. This Privacy Policy applies ONLY to information collected via The GHEP portal by the organization or those that it may hire to provide limited services on our behalf.

Credit card privacy. All credit card transactions are conducted over a secure system. Only authorized personnel with specific identification and passwords can access credit card information solely for the purpose of performing adjustments or refunds at the customer’s request.

Limitation of Liability. Neither GHEP, which owns IJMA, the open-access journal, and the IJMA portal, nor any of its subsidiaries or affiliate entities, agents, employees, or subcontractors shall be liable for any direct, indirect, special, incidental, consequential, punitive, or exemplary damages, including lost profits (even if we are advised of the possibility) arising in any way from the information contained in this Web site or any information transmitted via this web site. The GHEP is not liable for any damages or losses that may be caused to any equipment and other software due to any viruses, defects or malfunctions in connection with access or use of the IJMA portal web sites.

Contact us. We welcome your feedback. If you have questions or comments about our Privacy Policy, please contact us at

Last Updated: October 28, 2016.


Copyright 2018. All rights reserved. Global Health and Education Projects.
PO Box 234, Riverdale, Maryland, 20738, USA
Open Journal Systems